The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, M. A.
Right arrow Articles by Larsen, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, M. A.
Right arrow Articles by Larsen, C. P.
The Journal of Immunology, 2000, 165: 6849-6857.
Copyright © 2000 by The American Association of Immunologists

Genetic Characterization of Strain Differences in the Ability to Mediate CD40/CD28-Independent Rejection of Skin Allografts1

Matthew A. Williams, Joel Trambley, Jongwon Ha, Andrew B. Adams, Megan M. Durham, Phyllis Rees, Shannon R. Cowan, Thomas C. Pearson2 and Christian P. Larsen2

The Carlos and Marguerite Mason Transplantation Research Center, Department of Surgery, Emory University School of Medicine, Atlanta, GA 30322

Simultaneous blockade of the CD40 and CD28 T cell costimulatory pathways effectively promotes skin allograft survival in C3H/HeJ mice, extending median survival times (MSTs) beyond 100 days. This strategy is markedly less effective in C57BL/6 mice, with MSTs ranging between 20 and 30 days. In this study, we investigate the underlying genetic causes of these distinct phenotypes. Using H-2 congenic mice, we show that the genetic basis for the varied responses between these two strains is independent of the H-2 locus and T cell precursor frequency. C57BL/6 mice treated with costimulation blockade are able to generate allospecific CTL- and IFN-{gamma}-producing T cells within 3–4 wk posttransplant, whereas mice with a C3H background generate neither CTL- nor IFN-{gamma}-producing cells. Thus, differences appear to be in the generation of the immune response and not T cell homing. Strain differences in costimulation blockade-induced hyporesponsiveness persist in the absence of CD4+ T cells, implying a direct effect on CD8+ T cells. We demonstrate that genetic differences are important in cells of hemopoietic origin and that the costimulation blockade-resistant phenotype is dominant. Analysis of BXH recombinant inbred strains indicates that multiple loci contribute to the phenotype, and that the blockade resistance loci are preliminarily linked to 17 markers on four chromosomes. We conclude that strain variation in allograft MSTs following CD40/CD28 blockade results from the ability of CD8+ T cells in some strains to use alternative modes of costimulation to mount an effective alloresponse.




This article has been cited by other articles:


Home page
 BloodHome page
H. Xu, J. Yan, Y. Huang, P. M. Chilton, C. Ding, C. L. Schanie, L. Wang, and S. T. Ildstad
Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization
Blood, March 15, 2008; 111(6): 3266 - 3275.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. C. Kemball, E. Szomolanyi-Tsuda, and A. E. Lukacher
Allogeneic Differences in the Dependence on CD4+ T-Cell Help for Virus-Specific CD8+ T-Cell Differentiation
J. Virol., December 15, 2007; 81(24): 13743 - 13753.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
G. Yu, X. Xu, M. D. Vu, E. D. Kilpatrick, and X. C. Li
NK cells promote transplant tolerance by killing donor antigen-presenting cells
J. Exp. Med., August 7, 2006; 203(8): 1851 - 1858.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. C. Kemball, E. D. H. Lee, E. Szomolanyi-Tsuda, T. C. Pearson, C. P. Larsen, and A. E. Lukacher
Costimulation Requirements for Antiviral CD8+ T Cells Differ for Acute and Persistent Phases of Polyoma Virus Infection
J. Immunol., February 1, 2006; 176(3): 1814 - 1824.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Sho, K. Kishimoto, H. Harada, M. Livak, A. Sanchez-Fueyo, A. Yamada, X. X. Zheng, T. B. Strom, G. P. Basadonna, M. H. Sayegh, et al.
Requirements for induction and maintenance of peripheral tolerance in stringent allograft models
PNAS, September 13, 2005; 102(37): 13230 - 13235.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
A Davidson, B Diamond, D Wofsy, and D Daikh
Block and tackle: CTLA4Ig takes on lupus
Lupus, March 1, 2005; 14(3): 197 - 203.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
M. J. Nathan, J. E. Mold, S. C. Wood, K. Csencsits, G. Lu, E. J. Eichwald, and D. K. Bishop
Requirement for Donor and Recipient CD40 Expression in Cardiac Allograft Rejection: Induction of Th1 Responses and Influence of Donor-Derived Dendritic Cells
J. Immunol., June 1, 2004; 172(11): 6626 - 6633.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. van Maurik, B. F. de St. Groth, K. J. Wood, and N. D. Jones
Dependency of Direct Pathway CD4+ T Cells on CD40-CD154 Costimulation Is Determined by Nature and Microenvironment of Primary Contact with Alloantigen
J. Immunol., February 15, 2004; 172(4): 2163 - 2170.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Demirci, F. Amanullah, R. Kewalaramani, H. Yagita, T. B. Strom, M. H. Sayegh, and X. C. Li
Critical Role of OX40 in CD28 and CD154-Independent Rejection
J. Immunol., February 1, 2004; 172(3): 1691 - 1698.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Wang, K. A. Hosiawa, W. Min, J. Yang, X. Zhang, B. Garcia, T. E. Ichim, D. Zhou, D. Lian, D. J. Kelvin, et al.
Cytokines Regulate the Pattern of Rejection and Susceptibility to Cyclosporine Therapy in Different Mouse Recipient Strains After Cardiac Allografting
J. Immunol., October 1, 2003; 171(7): 3823 - 3836.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
N. Ardjomand, J. C. McAlister, N. J. Rogers, P. H. Tan, A. J. T. George, and D. F. P. Larkin
Modulation of Costimulation by CD28 and CD154 Alters the Kinetics and Cellular Characteristics of Corneal Allograft Rejection
Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3899 - 3905.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
L. Makhlouf, A. Yamada, T. Ito, R. Abdi, M. J. I. Ansari, C. Q. Khuong, H. J. Winn, H. Auchincloss Jr., and M. H. Sayegh
Allorecognition and Effector Pathways of Islet Allograft Rejection in Normal versus Nonobese Diabetic Mice
J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2168 - 2175.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Zhai, L. Meng, R. W. Busuttil, M. H. Sayegh, and J. W. Kupiec-Weglinski
Activation of Alloreactive CD8+ T Cells Operates Via CD4-Dependent and CD4-Independent Mechanisms and Is CD154 Blockade Sensitive
J. Immunol., March 15, 2003; 170(6): 3024 - 3028.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. v. Maurik, M. Herber, K. J. Wood, and N. D. Jones
Cutting Edge: CD4+CD25+ Alloantigen-Specific Immunoregulatory Cells That Can Prevent CD8+ T Cell-Mediated Graft Rejection: Implications for Anti-CD154 Immunotherapy
J. Immunol., November 15, 2002; 169(10): 5401 - 5404.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. Makhlouf, K. Kishimoto, R. N. Smith, R. Abdi, M. Koulmanda, H. J. Winn, H. Auchincloss Jr, and M. H. Sayegh
The Role of Autoimmunity in Islet Allograft Destruction: Major Histocompatibility Complex Class II Matching Is Necessary for Autoimmune Destruction of Allogeneic Islet Transplants After T-Cell Costimulatory Blockade
Diabetes, November 1, 2002; 51(11): 3202 - 3210.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. R. Nicolls, M. Coulombe, J. Beilke, H. C. Gelhaus, and R. G. Gill
CD4-Dependent Generation of Dominant Transplantation Tolerance Induced by Simultaneous Perturbation of CD154 and LFA-1 Pathways
J. Immunol., November 1, 2002; 169(9): 4831 - 4839.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Shirasugi, A. B. Adams, M. M. Durham, A. E. Lukacher, H. Xu, P. Rees, S. R. Cowan, M. A. Williams, T. C. Pearson, and C. P. Larsen
Prevention of Chronic Rejection in Murine Cardiac Allografts: A Comparison of Chimerism- and Nonchimerism-Inducing Costimulation Blockade-Based Tolerance Induction Regimens
J. Immunol., September 1, 2002; 169(5): 2677 - 2684.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. M. Onami, L. E. Harrington, M. A. Williams, M. Galvan, C. P. Larsen, T. C. Pearson, N. Manjunath, L. G. Baum, B. D. Pearce, and R. Ahmed
Dynamic Regulation of T Cell Immunity by CD43
J. Immunol., June 15, 2002; 168(12): 6022 - 6031.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Demirci, W. Gao, X. X. Zheng, T. R. Malek, T. B. Strom, and X. C. Li
On CD28/CD40 Ligand Costimulation, Common {gamma}-Chain Signals, and the Alloimmune Response
J. Immunol., May 1, 2002; 168(9): 4382 - 4390.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. R. Jones, J. Ha, M. A. Williams, A. B. Adams, M. M. Durham, P. A. Rees, S. R. Cowan, T. C. Pearson, and C. P. Larsen
The Role of the IL-2 Pathway in Costimulation Blockade-Resistant Rejection of Allografts
J. Immunol., February 1, 2002; 168(3): 1123 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. N. Iwakoshi, T. G. Markees, N. Turgeon, T. Thornley, A. Cuthbert, J. Leif, N. E. Phillips, J. P. Mordes, D. L. Greiner, and A. A. Rossini4
Skin Allograft Maintenance in a New Synchimeric Model System of Tolerance
J. Immunol., December 1, 2001; 167(11): 6623 - 6630.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. A. Williams, J. T. Tan, A. B. Adams, M. M. Durham, N. Shirasugi, J. K. Whitmire, L. E. Harrington, R. Ahmed, T. C. Pearson, and C. P. Larsen
Characterization of Virus-Mediated Inhibition of Mixed Chimerism and Allospecific Tolerance
J. Immunol., November 1, 2001; 167(9): 4987 - 4995.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.